As regulatory expectations rise and advanced therapies push cold-chain complexity, 3PLs are investing in validated infrastructure, network-wide quality systems, and data-driven visibility.

The tender offer is for €51.29 per share, representing a 13% premium on Recordati’s share price before the takeover was first disclosed.

Gilead Sciences has concluded its acquisition of Germany-based biotechnology company Tubulis in a transaction valued at up to $5bn.

Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis.

Bristol Myers Squibb (BMS) has signed a strategic agreement with Anthropic to implement its Claude platform across its global operations.

Eli Lilly has acquired Engage Bio and its preclinical, non-viral DNA delivery platform. Credit: Tada Images / Shutterstock.com. Pharmaceutical giant Eli Lilly has agreed to acquire Engage Biologics ...

The healthcare team covers Q1 results from pharma and medtech companies and provides a wrap-up of the key takeaways ...

FUJIFILM Cellular Dynamics has opened a new headquarters and iPSC manufacturing facility in Madison, Wisconsin, US.

Takeda has been ordered to pay $885m – potentially rising to $2.5bn – after a landmark court case verdict found the Japanese pharma company liable for a conspired arrangement ...

QIAGEN’s Digital Insights bioinformatics division is set to integrate NVIDIA’s accelerated computing and the BioNeMo platform to enhance AI-driven drug discovery.

Positive Trikafta results set a benchmark of efficacy for future CF therapies. Photo by filadendron/E+ via . On 18 May, at the 2026 American Thoracic Society (ATS) international conference, during a ...

SERB Pharmaceuticals has signed an agreement to acquire exclusive development and commercialisation rights to Idefirix from Hansa Biopharma for a total of $133.6m.